The Latest Breaking News from HBM

SK hynix and TSMC announced early on Friday that they had signed a memorandum of understanding to collaborate on developing the next-generation HBM4 memory and advanced packaging technology. The initiative is designed to speed up the adoption of HBM4 memory and solidify SK hynix's and TSMC's leading positions in high-bandwidth…

Offering some rare insight into the scale of HBM memory sales – and on its growth in the face of unprecedented demand from AI accelerator vendors – the company recently disclosed that it expects HBM sales to make up "a double-digit percentage of its DRAM chip sales" this year. Which…

Harbour BioMed has announced a global out-license agreement with AstraZeneca plc (NASDAQ:AZN) for CLDN18.2xCD3 bispecific antibody (HBM7022). HBM7022 is a novel bispecific antibody generated from HBM's HCAb Based Immune Cell Engagers (HBICE) Platform.  HBM7022 is currently in the preclinical stage, which crosslinks tumor cells and T cells by targeting a tumor-associated antigen (Claudin18.2) and…

Copper prices are currently hovering near all-time highs due to fears of supply disruptions and low stockpiles. As the world transitions towards clean energy, the demand for copper, a widely used metal in energy generation, is expected to keep surging, leading to a further increase in its prices. Fundamentally strong…

  Hudbay Minerals (NYSE:HBM) reported its Q4 earnings results on Wednesday, February 23, 2022 at 06:00 PM. Here's what investors need to know about the announcement.

Hudbay Minerals (NYSE:HBM) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts estimate that Hudbay Minerals will report an earnings per share (EPS) of $0.13.